Upgrade to SI Premium - Free Trial

RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'

April 2, 2026 8:07 AM
RBC Capital analyst Luca Issi reiterated an Outperform rating and $360.00 price target on Amgen (NASDAQ: AMGN).The analyst commented: "AMGN ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments